Cream containing 4% hydroquinone, 0.05% tretinoin and 0.01% fluocinolone acetonide is the approved combination for treatment of moderate to severe melasma. This slide set discusses the rationale for the triple combination, and also the pharmacokinetic, efficacy and safety aspects of the combination.